S100A9 and hepatocellular carcinoma: Another study suggested that the activation of the MAPK/p38 signaling pathway induced by S100A9 contributes to enhanced cell invasion and growth in HCC patients [29], and additionally, this pathway was realized to also be induced by BMPs, leading to osteoblastic differentiation and mineralization [30].